Friday 17 September
Homologous Recombination Deficiency: BRCA and Beyond
Friday, 08:45 - 09:50
View the satellite invitation
From Breast Cancer Biology to Therapy
Friday, 08:45 - 10:15
View the satellite invitation
The Role of Biomarkers in Patient Management in Immuno-Oncology
Friday, 10:30 - 11:30
View the satellite invitation
Saturday 18 September
Confidence and Clarity in Advanced Breast Cancer: Insights From The Real World
Saturday, 10:30 - 12:00
View the satellite invitation
Navigating a New Era in HER2+ Metastatic Breast Cancer: Focus on HER2CLIMB
Saturday, 10:30 - 12:00
View the satellite invitation
Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies
Saturday, 18:45 - 20:15
View the satellite invitation
Sunday 19 September
Improving Survival Outcomes in HR+/HER2− Advanced Breast Cancer: A Biological Perspective
Sunday, 10:30 - 12:00
View the satellite invitation
Monday 20 September
Developments in Precision Medicine for Breast and Ovarian Cancers
Monday, 08:45 - 10:15
View the satellite invitation
Triple-Negative Breast Cancer: See Beyond the Negatives
Monday, 18:45 - 20:15
View the satellite invitation
Tuesday 21 September
Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors
Tuesday, 10:30 - 12:00
View the satellite invitation
Emerging Agents in Breast Cancer Care
Tuesday, 17:35 - 19:05
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme